NCT07454226 2026-04-16
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
Clinical Trials
12 trialsNCT07074756 2026-03-27
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma
Mayo Clinic
Phase NA Recruiting
NCT07044362 2026-03-19
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT03785574 2026-03-16
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05378334 2026-03-10
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
Guangzhou University of Traditional Chinese Medicine
Phase NA Recruiting
NCT01928589 2026-03-06
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer
Indiana University
Phase NA Active not recruiting
NCT07452003 2026-03-05
An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
Peking Union Medical College Hospital
Phase NA Recruiting
NCT04798664 2026-02-25
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT06353646 2026-02-13
XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
Peking Union Medical College Hospital
Phase NA Recruiting
NCT05488626 2026-02-05
ARTIA-Lung
Varian, a Siemens Healthineers Company
Phase NA Withdrawn
NCT03210103 2026-01-28
ORATOR2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Active not recruiting
NCT07188532 2026-01-23
BEAR
Mayo Clinic
Phase NA Recruiting